Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1614 1645 1651 1653 1797
This examiner grants 0% of resolved cases
Examiner ENUSHA KARUNASENA is assigned to Tech Center 1700 and Art Unit 1614. The examiner has 2 resolved cases, which represents a nascent data set for this prosecution profile. With only 2 resolved cases, the current metrics are highly sensitive to the outcome of each individual application.
The allowance rate is 0.0 percent. This 0.0 percent rate reflects the outcome of the 2 resolved cases, neither of which resulted in a patent grant. The median days to allowance is 824, though this figure is based on a very limited history. Practitioners should view the 824 day metric as a preliminary data point for Art Unit 1614.
The interview lift is 0.0 percent. This 0.0 percent lift indicates that interviews have not yet been associated with a successful outcome compared to the 0.0 percent baseline. Given the allowance rate, applicants should be aware that these early metrics may change as the examiner handles more resolutions. The data from Tech Center 1700 will evolve as the total number of resolved cases increases.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18268925 | METHODS FOR ASSAYING TARGET PROTEINS ON EXTRACELLULAR VESICLES IN PLASMA | Non-Final OA | Verily Life Sciences LLC |
| 18586896 | CETYLTRIMETHYLAMMONIUM BROMIDE (CTAB) AS A LYSIS AND FLOCCULATION REAGENT IN GENE THERAPY DOWNSTREAM PROCESSES | Non-Final OA | Pfizer Inc. |
| 18325900 | Endophytic Pediococcus pentosaceus EL5 in alfalfa and application thereof | Final Rejection | CHINA AGRICULTURAL UNIVERSITY |
| 18530406 | COMBINED TREATMENT FOR CANCER | Non-Final OA | Yeda Research and Development Co. Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy